ABCB1 and cancer: In these studies, it was observed that the anticancer drug hesperidin/hesperetin combination leads to an increase in the bioavailability of the anticancer drug and enhances the effectiveness of therapy, attributed to the ability to inhibit the action of P-glycoprotein, which is the main factor of multidrug resistance in cancer cells [21,22,23].